THREAD and SEQSTER announce partnership to enhance clinical research with integrated primary study and real-world data

The two companies are collaborating to offer a streamlined solution that combines primary study data, captured on THREAD’s platform, with real-world data available through SEQSTER’s patient-centric operating system. 

SEQSTER, a patient-centric healthcare data technology company, and THREAD, a decentralized research and electronic clinical outcome assessments (eCOA) provider, have announced a strategic collaboration to accelerate clinical research studies. Through this partnership, primary data captured via THREAD’s research platform is combined with instant access to secondary electronic health record data from SEQSTER. This integration broadens the scope of participant data and offers valuable insights into participant eligibility for research, as well as evidence for demonstrating the efficacy and safety of new medicines. Biopharma companies and clinical research organizations can leverage the increased data volume from clinical studies to assess the impact of medicines more quickly, ultimately accelerating drug development.

“Real-time data turbocharges decision-making, giving researchers a rapid pulse on trends and potential pitfalls, as patient-first trial technology improves the research experience overall. Together, they empower researchers to optimize trial design and then efficiently deliver against that design,” noted Ardy Arianpour, CEO & Co-Founder of SEQSTER.

Aaron Berger, SVP of Evidence Development at UBC continued, “Fragmentation of data for clinical research is a challenge for all research sponsors and we are excited to utilize this offering to support our clients. This partnership between THREAD and SEQSTER is an important step forward in improving the clinical research experience for sponsors, site staff and patients.”

In addition, the partnership will utilize THREAD’s proprietary patient listening technology, ensuring that real-world data collection in research studies is designed with direct patient feedback. As explained by John Reites, Co-founder, CEO of Thread:

“Our partnership with SEQSTER is impactful for both patients and researchers. By enabling real-time medical record access integrated with THREAD’s platform, we simplify the research experience and provide access to more data,”